Figure INF-10:  Prevalence of markers of HBV infection estimated among national and sub-national samples of injecting drug users 2003 to 2004, where data are available – Part (iii) Percentage positive for HBsAg (current infection) – map of EU

Figure INF-10 part iii

Notes:

Figures in (brackets) are local data. Colour indicates midpoint of national data, or if not available, of local data.

Data for Italy and Portugal include non-injectors and are likely to underestimate prevalence in injectors

See also 'General notes for interpreting data' on the Explanatory notes and help page.

Sources:

Reitox national focal points. For primary sources, study details and data before 2003, see Table INF-14.